Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus

American Journal of Gastroenterology

Volumn 112, Issue 5, 2017, Pages 775-784

  Rezaie, Ali ^a   Buresi, Michelle ^b   Lembo, Anthony ^c   Lin, Henry ^d   McCallum, Richard ^e   Rao, Satish ^f   Schmulson, Max ^g   Valdovinos, Miguel ^h   Zakko, Salam ⁱ   Pimentel, Mark ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^f MEDICAL COLLEGE OF GEORGIA   (United States)

^g UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^h INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

ⁱ Bristol Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LACTOSE; LACTULOSE; FRUCTOSE; HYDROGEN; METHANE;

ANTIBIOTIC THERAPY; ARTICLE; BLOATING; BREATH ANALYSIS; CARBOHYDRATE INTOLERANCE; CARBOHYDRATE MALDIGESTION SYNDROME; CLINICAL PRACTICE; CONSENSUS; CONSTIPATION; DIGESTIVE SYSTEM FUNCTION DISORDER; EVIDENCE BASED PRACTICE; GASTROINTESTINAL DISEASE; HUMAN; HYDROGEN BREATH TEST; METHANE BASED BREATH TESTING; NORTH AMERICAN; PRIORITY JOURNAL; SMALL INTESTINAL BACTERIAL OVERGROWTH; SMOKING; BLIND LOOP SYNDROME; CONSENSUS DEVELOPMENT; GASTROINTESTINAL DISEASES; LACTOSE INTOLERANCE; NORTH AMERICA; PATIENT SELECTION; PRACTICE GUIDELINE; PROCEDURES;

BLIND LOOP SYNDROME; BREATH TESTS; CONSENSUS; FRUCTOSE; GASTROINTESTINAL DISEASES; GLUCOSE; HUMANS; HYDROGEN; LACTOSE; LACTOSE INTOLERANCE; LACTULOSE; METHANE; NORTH AMERICA; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC;

EID: 85015715808     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2017.46     Document Type: Article

References (95)

1. Gasbarrini A, Corazza GR, Gasbarrini G et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther 2009; 29 (Suppl 1): 1-49.
2. Khoshini R, Dai SC, Lezcano S et al. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci 2008; 53: 1443-54.
3. de Boissieu D, Chaussain M, Badoual J et al. Small-bowel bacterial overgrowth in children with chronic diarrhea, abdominal pain, or both. J Pediatr 1996; 128: 203-7.
4. Lupascu A, Gabrielli M, Lauritano EC et al. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther 2005; 22: 1157-60.
5. Pignata C, Budillon G, Monaco G et al. Jejunal bacterial overgrowth and intestinal permeability in children with immunodeficiency syndromes. Gut 1990; 31: 879-82.
6. Trespi E, Ferrieri A. Intestinal bacterial overgrowth during chronic pancreatitis. Curr Med Res Opin 1999; 15: 47-52.
7. Yang CY, Chang CS, Chen GH. Small-intestinal bacterial overgrowth in patients with liver cirrhosis, diagnosed with glucose H2 or CH4 breath tests. Scand J Gastroenterol 1998; 33: 867-71.
8. Lewindon PJ, Robb TA, Moore DJ et al. Bowel dysfunction in cystic fibrosis: importance of breath testing. J Paediatr Child Health 1998; 34: 79-82.
9. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003; 98: 412-9.
10. Donald IP, Kitchingmam G, Donald F et al. The diagnosis of small bowel bacterial overgrowth in elderly patients. J Am Geriatr Soc 1992; 40: 692-6.
11. King CE, Toskes PP. Comparison of the 1-gram [14C]xylose, 10-gram lactulose-H2, and 80-gram glucose-H2 breath tests in patients with small intestine bacterial overgrowth. Gastroenterology 1986; 91: 1447-51.
12. Rhodes JM, Middleton P, Jewell DP. The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth. Scand J Gastroenterol 1979; 14: 333-6.
13. Stotzer PO, Kilander AF. Comparison of the 1-gram (14)C-D-xylose breath test and the 50-gram hydrogen glucose breath test for diagnosis of small intestinal bacterial overgrowth. Digestion 2000; 61: 165-71.
14. Teo M, Chung S, Chitti L et al. Small bowel bacterial overgrowth is a common cause of chronic diarrhea. J Gastroenterol Hepatol 2004; 19: 904-9.
15. Ghoshal UC, Ghoshal U, Das K et al. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time. Indian J Gastroenterol 2006; 25: 6-10.
16. Levitt MD, Bond JH Jr. Volume, composition, and source of intestinal gas. Gastroenterology 1970; 59: 921-9.
17. Levitt MD. Volume and composition of human intestinal gas determined by means of an intestinal washout technic. N Engl J Med 1971; 284: 1394-8.
18. Keller J, Franke A, Storr M et al. Clinically relevant breath tests in gastroenterological diagnostics-recommendations of the German Society for Neurogastroenterology and Motility as well as the German Society for Digestive and Metabolic Diseases. Z Gastroenterol 2005; 43: 1071-90.
19. Cook DJ, Greengold NL, Ellrodt AG et al. The relation between systematic reviews and practice guidelines. Ann Intern Med 1997; 127: 210-6.
20. Bressler B, Marshall JK, Bernstein CN et al. Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus. Gastroenterology 2015; 148: 1035-1058 e3.
21. Guyatt G, Oxman AD, Akl EA et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011; 64: 383-94.
22. Pimentel M, Chang C, Chua KS et al. Antibiotic treatment of constipation predominant irritable bowel syndrome. Dig Dis Sci 2014; 59: 1278-85.
23. Gilat T, Ben Hur H, Gelman-Malachi E et al. Alterations of the colonic flora and their effect on the hydrogen breath test. Gut 1978; 19: 602-5.
24. Lauritano EC, Gabrielli M, Scarpellini E et al. Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole. Eur Rev Med Pharmacol Sci 2009; 13: 111-6.
25. Di Stefano M, Malservisi S, Veneto G et al. Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2000; 14: 551-6.
26. Sen S, Mullan MM, Parker TJ et al. Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig Dis Sci 2002; 47: 2615-20.
27. Barrett JS, Canale KE, Gearry RB et al. Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome. World J Gastroenterol 2008; 14: 5020-4.
28. Pimentel M, Morales W, Lezcano S et al. Low-dose nocturnal tegaserod or erythromycin delays symptom recurrence aft er treatment of irritable bowel syndrome based on presumed bacterial overgrowth. Gastroenterol Hepatol (N Y) 2009; 5: 435-42.
29. Brummer RJ, Armbrecht U, Bosaeus I et al. The hydrogen (H2) breath test. Sampling methods and the influence of dietary fibre on fasting level. Scand J Gastroenterol 1985; 20: 1007-13.
30. Levitt MD, Hirsh P, Fetzer CA et al. H2 excretion aft er ingestion of complex carbohydrates. Gastroenterology 1987; 92: 383-9.
31. Di Stefano M, Miceli E, Missanelli A et al. Fermentation of endogenous substrates is responsible for increased fasting breath hydrogen levels in celiac disease. J Lab Clin Med 2004; 143: 163-8.
32. Tadesse K, Eastwood M. Breath-hydrogen test and smoking. Lancet 1977; 2: 91.
33. Rosenthal A, Solomons NW. Time-course of cigarette smoke contamination of clinical hydrogen breath-analysis tests. Clin Chem 1983; 29: 1980-1.
34. Miller G, Palmer KR, Smith B et al. Smoking delays gastric emptying of solids. Gut 1989; 30: 50-3.
35. Perman JA, Modler S, Engel RR et al. Effect of ventilation on breath hydrogen measurements. J Lab Clin Med 1985; 105: 436-9.
36. Law D, Pimentel M. Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS. Dig Dis Sci 2010; 55: 2302-8.
37. Lombardo L, Foti M, Ruggia O et al. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol 2010; 8: 504-8.
38. Rezaie A, Pimentel M, Rao SS. How to test and treat small intestinal bacterial overgrowth: an evidence-based approach. Curr Gastroenterol Rep 2016; 18: 8.
39. Simren M, Stotzer PO. Use and abuse of hydrogen breath tests. Gut 2006; 55: 297-303
40. Yamini D, Pimentel M. Irritable bowel syndrome and small intestinal bacterial overgrowth. J Clin Gastroenterol 2010; 44: 672-5.
41. Erdogan A, Rao SS, Gulley D et al. Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test. Neurogastroenterol Motil 2015; 27: 481-9.
42. Jacobs C, Coss Adame E, Attaluri A et al. Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth. Aliment Pharmacol Ther 2013; 37: 1103-11.
43. Olof H, Sundin AHML, Zeng M et al. The human jejunal microbiome has a distinctive bacterial flora, with streptococcus tigurinus as its signature species, and an increased fraction of gram-negative phyla in patients with small intestinal bacterial overgrowth. Gastroenterology 2016; 150: S689
44. Pyleris E, Giamarellos-Bourboulis EJ, Tzivras D et al. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci 2012; 57: 1321-9.
45. Giamarellos-Bourboulis E, Tang J, Pyleris E et al. Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome. Scand J Gastroenterol 2015; 50: 1076-87.
46. Lin EC, Massey BT. Scintigraphy demonstrates high rate of false-positive results from glucose breath tests for small bowel bacterial overgrowth. Clin Gastroenterol Hepatol 2016; 14: 203-8.
47. Yu D, Cheeseman F, Vanner S. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut 2011; 60: 334-40.
48. Pimentel M. Reply. Gastroenterology 2016; 150: 278-9.
49. Pimentel M, Lin HC, Enayati P et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am J Physiol Gastrointest Liver Physiol 2006; 290: G1089-G1095.
50. Chatterjee S, Park S, Low K et al. The degree of breath methane production in IBS correlates with the severity of constipation. Am J Gastroenterol 2007; 102: 837-41.
51. Attaluri A, Jackson M, Valestin J et al. Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS. Am J Gastroenterol 2010; 105: 1407-11.
52. Hwang L, Low K, Khoshini R et al. Evaluating breath methane as a diagnostic test for constipation-predominant IBS. Dig Dis Sci 2010; 55: 398-403.
53. Kunkel D, Basseri RJ, Makhani MD et al. Methane on breath testing is associated with constipation: a systematic review and meta-analysis. Dig Dis Sci 2011; 56: 1612-8.
54. Low K, Hwang L, Hua J et al. A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test. J Clin Gastroenterol 2010; 44: 547-50.
55. Read NW, Miles CA, Fisher D et al. Transit of a meal through the stomach, small intestine, and colon in normal subjects and its role in the pathogenesis of diarrhea. Gastroenterology 1980; 79: 1276-82.
56. Camboni G, Basilisco G, Bozzani A et al. Repeatability of lactulose hydrogen breath test in subjects with normal or prolonged orocecal transit. Dig Dis Sci 1988; 33: 1525-7.
57. Miller MA, Parkman HP, Urbain JL et al. Comparison of scintigraphy and lactulose breath hydrogen test for assessment of orocecal transit: lactulose accelerates small bowel transit. Dig Dis Sci 1997; 42: 10-18.
58. Geboes KP, Luypaerts A, Rutgeerts P et al. Inulin is an ideal substrate for a hydrogen breath test to measure the orocaecal transit time. Aliment Pharmacol Ther 2003; 18: 721-9.
59. Suchy FJ, Brannon PM, Carpenter TO et al. NIH consensus development conference statement: Lactose intolerance and health. NIH Consens State Sci Statements 2010; 27: 1-27.
60. Maiuri L, Raia V, Potter J et al. Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia. Gastroenterology 1991; 100: 359-69.
61. Sibley E. Genetic variation and lactose intolerance: detection methods and clinical implications. Am J Pharmacogenomics 2004; 4: 239-45.
62. Hovde O, Farup PG. A comparison of diagnostic tests for lactose malabsorption-which one is the best? BMC Gastroenterol 2009; 9: 82.
63. Rezaie A, Chang B, Chua KS et al. Accurate identification of excessive methane gas producers by a single fasting measurement of exhaled methane: a large-scale database analysis. Am J Gastroenterol 2015; 110: S684.
64. Nucera G, Gabrielli M, Lupascu A et al. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2005; 21: 1391-5.
65. Pimentel M, Kong Y, Park S. Breath testing to evaluate lactose intolerance in irritable bowel syndrome correlates with lactulose testing and may not reflect true lactose malabsorption. Am J Gastroenterol 2003; 98: 2700-4.
66. Fedewa A, Rao SS. Dietary fructose intolerance, fructan intolerance and FODMAPs. Curr Gastroenterol Rep 2014; 16: 370.
67. Rao SS, Attaluri A, Anderson L et al. Ability of the normal human small intestine to absorb fructose: evaluation by breath testing. Clin Gastroenterol Hepatol 2007; 5: 959-63.
68. Corazza GR, Strocchi A, Rossi R et al. Sorbitol malabsorption in normal volunteers and in patients with coeliac disease. Gut 1988; 29: 44-8.
69. Peuhkuri K, Vapaatalo H, Korpela R et al. Lactose intolerance-a confusing clinical diagnosis. Am J Clin Nutr 2000; 71: 600-2.
70. Shah ED, Basseri RJ, Chong K et al. Abnormal breath testing in IBS: a metaanalysis. Dig Dis Sci 2010; 55: 2441-9.
71. Pourmorady J, Shah E, Rezaie A et al. Breath testing for small intestinal bacterial overgrowth in irritable bowel syndrome: A meta-analysis. Am J Gastroenterol 2015; 110: S762.
72. Riordan SM, McIver CJ, Walker BM et al. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol 1996; 91: 1795-803.
73. Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology 1988; 95: 982-8.
74. Metz G, Gassull MA, Drasar BS et al. Breath-hydrogen test for small-intestinal bacterial colonisation. Lancet 1976; 1: 668-9.
75. Bauer TM, Schwacha H, Steinbruckner B et al. Diagnosis of small intestinal bacterial overgrowth in patients with cirrhosis of the liver: poor performance of the glucose breath hydrogen test. J Hepatol 2000; 33: 382-6.
76. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-53.
77. Johnson AO, Semenya JG, Buchowski MS et al. Adaptation of lactose maldigesters to continued milk intakes. Am J Clin Nutr 1993; 58: 879-81.
78. Hertzler SR, Huynh BC, Savaiano DA. How much lactose is low lactose? J Am Diet Assoc 1996; 96: 243-6.
79. Hertzler SR, Savaiano DA. Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance. Am J Clin Nutr 1996; 64: 232-6.
80. Arvanitakis C, Chen GH, Folscroft J et al. Lactase deficiency-a comparative study of diagnostic methods. Am J Clin Nutr 1977; 30: 1597-602.
81. Riby JE, Fujisawa T, Kretchmer N. Fructose absorption. Am J Clin Nutr 1993; 58: 748 S - 53 S.
82. Rumessen JJ, Gudmand-Hoyer E. Absorption capacity of fructose in healthy adults. Comparison with sucrose and its constituent monosaccharides. Gut 1986; 27: 1161-8.
83. Law D, Conklin J, Pimentel M. Lactose intolerance and the role of the lactose breath test. Am J Gastroenterol 2010; 105: 1726-8.
84. Hermans MM, Brummer RJ, Ruijgers AM et al. The relationship between lactose tolerance test results and symptoms of lactose intolerance. Am J Gastroenterol 1997; 92: 981-4.
85. Sung HY, Kim YS. Fructose malabsorption in patients with irritable bowel syndrome-like symptoms: what is the role in the pathogenesis and clinical implication? J Neurogastroenterol Motil 2014; 20: 135-7.
86. Goldoni M, Corradi M, Mozzoni P et al. Concentration of exhaled breath condensate biomarkers aft er fractionated collection based on exhaled CO2 signal. J Breath Res 2013; 7: 017101.
87. Chang BW, Chua KS, Lin E et al. Understanding the significant interaction between hydrogen and methane in the performance and interpretation of breath testing. Gastroenterology 2015; 148: S-729.
88. Bauchop T, Mountfort DO. Cellulose fermentation by a rumen anaerobic fungus in both the absence and the presence of rumen methanogens. Appl Environ Microbiol 1981; 42: 1103-10.
89. Krajmalnik-Brown R, Ilhan ZE, Kang DW et al. Effects of gut microbes on nutrient absorption and energy regulation. Nutr Clin Pract 2012; 27: 201-14.
90. Truswell AS, Seach JM, Thorburn AW. Incomplete absorption of pure fructose in healthy subjects and the facilitating effect of glucose. Am J Clin Nutr 1988; 48: 1424-30.
91. Erdogan A, Lee YY, Badger C et al. What is the optimal threshold for an increase in hydrogen and methane levels with glucose breath test (GBT) for detection of small intestinal bacterial overgrowth (SIBO)? Gastroenterology 2014; 146: S-532.
92. George NS, Sankineni A, Parkman HP. Small intestinal bacterial overgrowth in gastroparesis. Dig Dis Sci 2014; 59: 645-52.
93. Chang BW, Pimentel M, Chang C et al. Prevalence of excessive intestinal methane production and its variability with age and gender: a large-scale database analysis. Gastroenterology 2015; 148: S-729-S-730.
94. Strocchi A, Furne JK, Ellis CJ et al. Competition for hydrogen by human faecal bacteria: evidence for the predominance of methane producing bacteria. Gut 1991; 32: 1498-501.
95. QT02444 Catalog Rev B Quin Tron Instrument Company, Inc: 2009.